New strategies and advances on diagnosis and treatment of patients with HBV related acute-on-chronic liver failure
Fangji YANG; Liang PENG; Zhiliang GAO.
Chinese Journal of Clinical Infectious Diseases
; (6): 101-106, 2017.
ArtÃculo en Zh | WPRIM | ID: wpr-608545
Documentos relacionados
Biomedical research in france and brazil: an analysis of significant differences and ethical issues
[Definition and diagnosis of acute-on-chronic liver failure: new knowledge and implication].
Reversibility of acute-on-chronic liver failure syndrome in hepatitis B virus-infected patients with and without prior decompensation.
Characterization of the Clinical Features in HBV-Related Acute-on-Chronic Liver Failure.
Soluble urokinase plasminogen activator receptor is associated with short-term mortality and enhanced reactive oxygen species production in acute-on-chronic liver failure.
Serum Interleukins as Potential Prognostic Biomarkers in HBV-Related Acute-on-Chronic Liver Failure.
Prognostic value of plasma level of superoxide dismutase in HBV-related acute-on-chronic liver failure.
[Assessment of liver transplant benefit and a novel strategy for liver donor allocation in acute-on-chronic liver failure].
[Acute-on-chronic liver failure: definition, diagnosis, and pathogenesis].
Acute-on-chronic liver failure: update on pathogenesis, therapeutic targets, predictive models, and liver transplantation.